Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol

Annu Arora1, Yogeshwer Shukla

  • 1Environmental Carcinogenesis Division, Industrial Toxicology Research Centre, M.G. Marg, P.O. Box 80, Lucknow-226001, India.

Cancer Letters
|December 20, 2002
PubMed

Insights

Indole-3-carbinol (I3C) effectively reverses P-glycoprotein (P-gp) over-expression, a cause of cancer drug resistance. This finding suggests I3C

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • P-glycoprotein (P-gp) over-expression, encoded by the mdr-1 gene, is a key mechanism of multidrug resistance in cancer chemotherapy.
  • Vinca-alkaloids like vinblastine and vincristine are known to induce mdr-1 gene expression and P-gp over-expression.

Purpose of the Study:

  • To investigate the potential of indole-3-carbinol (I3C) to modulate P-gp over-expression induced by vinblastine or vincristine.
  • To evaluate I3C as a dietary adjuvant for reversing multidrug resistance in cancer treatment.

Main Methods:

  • Western blotting using a monoclonal antibody (clone JSB1) to detect P-gp levels.
  • Immunohistochemical staining of tissue sections followed by image analysis for P-gp quantification.

Main Results:

  • I3C significantly reversed the over-expression of P-gp induced by vinblastine and vincristine.
  • Image analysis confirmed that I3C effectively inhibited P-gp over-expression in vinca-alkaloid treated samples.

Conclusions:

  • Indole-3-carbinol (I3C) demonstrates significant potential in inhibiting P-gp over-expression.
  • I3C may serve as a valuable dietary adjuvant to overcome multidrug resistance in cancer therapy.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...